SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-069063
Filing Date
2024-08-14
Accepted
2024-08-14 16:25:46
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0211372-10q_ostherap.htm   iXBRL 10-Q 690396
2 OS THERAPIES INCORPORATED 2023 INCENTIVE COMPENSATION PLAN, AS AMENDED ea021137201ex10-7_ostherap.htm EX-10.7 130820
3 CERTIFICATION ea021137201ex31-1_ostherap.htm EX-31.1 7914
4 CERTIFICATION ea021137201ex31-2_ostherap.htm EX-31.2 7700
5 CERTIFICATION ea021137201ex32_ostherap.htm EX-32 6447
  Complete submission text file 0001213900-24-069063.txt   4472390

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE osti-20240630.xsd EX-101.SCH 56565
7 XBRL CALCULATION FILE osti-20240630_cal.xml EX-101.CAL 24289
8 XBRL DEFINITION FILE osti-20240630_def.xml EX-101.DEF 217732
9 XBRL LABEL FILE osti-20240630_lab.xml EX-101.LAB 417294
10 XBRL PRESENTATION FILE osti-20240630_pre.xml EX-101.PRE 226040
61 EXTRACTED XBRL INSTANCE DOCUMENT ea0211372-10q_ostherap_htm.xml XML 477654
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

IRS No.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42195 | Film No.: 241208434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)